Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Director/PDMR Shareholding

17 Jun 2024 16:00

RNS Number : 7453S
Experian plc
17 June 2024
Β 

Experian plc

Β 

Β 

Director/PDMR Shareholding

Β 

Β 

[ ] June 2024 - Experian plc, the global data and technology company, hereby notifies the market that it has received notification (made under article 19.1 of the UK Market Abuse Regulation ("MAR")) of the following transactions in its ordinary shares of 10 US cents each ("ordinary shares") by directors of the Company.

Β 

Co-Investment Plan

Β 

In accordance with the terms of the Experian Co-Investment Plan, the Company made awards over its ordinary shares on 14 June 2024 to certain directors by reference to a price of 3,717.373 pence per share. The awards of deferred matching ordinary shares are subject to performance conditions and the maximum numbers of shares that could vest in the case of each director are set out below.

Name of director/PDMR

Number of deferred

ordinary shares

Maximum number of deferred matching ordinary shares

Brian Cassin

28,937

109,196

Lloyd Pitchford

19,090

72,040

Craig Boundy

41,953

83,906

Β 

Note: The deferred ordinary share awards for Brian Cassin and Lloyd Pitchford were calculated with reference to their bonuses net of tax. The deferred ordinary share award for Craig Boundy was calculated with reference to his gross bonus and will be taxed at the point of vesting. All deferred matching ordinary share awards were calculated on a gross basis and will be taxed at the point of vesting.

Β 

Performance Share Plan

Β 

In accordance with the terms of the Experian Performance Share Plan, the Company made awards over its ordinary shares on 14 June 2024 to certain directors by reference to a price of 3,726.00 pence per share. The awards are subject to performance conditions and the maximum number of shares that could vest in the case of each director is set out below.

Β 

Name of director/PDMR

Maximum number

of ordinary shares

Brian Cassin

57,434

Lloyd Pitchford

40,257

Craig Boundy

44,181

Β 

The following individual notifications are made in accordance with Article 19.3 of MAR.

Β 

Β 

1 - Details of the person discharging managerial responsibilities / person closely associated

Β 

Β 

Β 

Natural Person

Brian Cassin

Β 

Β 

2 - Reason for the notification

Β 

Β 

Β 

Position/status

Director and Chief Executive Officer

Β 

Β 

Initial notification / Amendment

Initial Notification

Β 

Β 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

Β 

Β 

Β 

Full name of the entity

Experian plc

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

Β 

Β 

Β 

4 - Details of the transaction(s)

Β 

Β 

Β 

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary shares of US 10 cents each in Experian plc

Β 

Identification Code

GB00B19NLV48

Β 

Β 

Nature of transaction

(1) Acquisition of shares, being the award of Invested Shares ("deferred ordinary shares") for market value under the Experian Co-Investment Plan.

Β 

(2) Grant of a conditional right to receive shares for nil consideration, being the grant of a Matching Award ("deferred matching ordinary shares") under the Experian Co-Investment Plan.

Β 

(3) Grant of a conditional right to receive shares for nil consideration, being the grant of an award under the Experian Performance Share Plan.

Β 

Β 

Currency

GBP

Β 

Β 

Prices(s) and volumes(s)

Transaction

Price

Volume

No (1)

3,717.373 pence

28,937

No (2)

Nil

109,196

No (3)

Nil

57,434

Β 

Β 

Aggregated Information

Transaction

Price

Volume

No (1)

3,717.373 pence

28,937

No (2) and (3)

Nil

166,630

Β 

Β 

Date of Transaction

Β 

2024-06-14

Β 

Β 

Place of transaction

Acquisition: XLON

Grant of conditional rights: Outside a trading venue

Β 

Β 

Β 

Β 

Β 

Β 

1 - Details of the person discharging managerial responsibilities / person closely associated

Β 

Β 

Β 

Natural Person

Lloyd Pitchford

Β 

Β 

2 - Reason for the notification

Β 

Β 

Β 

Position/status

Director and Chief Financial Officer

Β 

Β 

Initial notification / Amendment

Initial Notification

Β 

Β 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

Β 

Β 

Full name of the entity

Experian plc

Β 

Β 

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

Β 

Β 

Β 

Β 

4 - Details of the transaction(s)

Β 

Β 

Β 

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary shares of US 10 cents each in Experian plc

Β 

Identification Code

GB00B19NLV48

Β 

Β 

Nature of transaction

(1) Acquisition of shares, being the award of Invested Shares ("deferred ordinary shares") for market value under the Experian Co-Investment Plan.

Β 

(2) Grant of a conditional right to receive shares for nil consideration, being the grant of a Matching Award ("deferred matching ordinary shares") under the Experian Co-Investment Plan.

Β 

(3) Grant of a conditional right to receive shares for nil consideration, being the grant of an award under the Experian Performance Share Plan.

Β 

Β 

Currency

GBP

Β 

Β 

Prices(s) and volumes(s)

Transaction

Price

Volume

No (1)

3,717.373 pence

19,090

No (2)

Nil

72,040

No (3)

Nil

40,257

Β 

Β 

Aggregated Information

Transaction

Price

Volume

No (1)

3,717.373 pence

19,090

No (2) and (3)

Nil

112,297

Β 

Β 

Date of Transaction

Β 

2024-06-14

Β 

Β 

Place of transaction

Acquisition: XLON

Grant of conditional rights: Outside a trading venue

Β 

Β 

Β 

Β 

Β 

Β 

1 - Details of the person discharging managerial responsibilities / person closely associated

Β 

Β 

Β 

Natural Person

Craig Boundy

Β 

Β 

2 - Reason for the notification

Β 

Β 

Β 

Position/status

Director and Chief Operating Officer

Β 

Β 

Initial notification / Amendment

Initial Notification

Β 

Β 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

Β 

Β 

Full name of the entity

Experian plc

Β 

Β 

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

Β 

Β 

Β 

Β 

4 - Details of the transaction(s)

Β 

Β 

Β 

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary shares of US 10 cents each in Experian plc

Β 

Identification Code

GB00B19NLV48

Β 

Β 

Nature of transaction

(1) Grant of a conditional right to receive shares for nil consideration, being the grant of Deferred Shares ("deferred ordinary shares") under the Experian Co-Investment Plan.

Β 

(2) Grant of a conditional right to receive shares for nil consideration, being the grant of a Matching Award ("deferred matching ordinary shares") under the Experian Co-Investment Plan.

Β 

(3) Grant of a conditional right to receive shares for nil consideration, being the grant of an award under the Experian Performance Share Plan.

Β 

Β 

Currency

GBP

Β 

Β 

Prices(s) and volumes(s)

Transaction

Price

Volume

No (1)

Nil

41,953

No (2)

Nil

83,906

No (3)

Nil

44,181

Β 

Β 

Aggregated Information

Price

Volume

Nil

170,040

Β 

Β 

Date of Transaction

Β 

2024-06-14

Β 

Β 

Place of transaction

Outside a trading venue

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Contact:

Β 

Experian

Ronan Hanna Deputy Company Secretary +353 (0) 86 380 2797

Β 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Β 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

Β 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHGPUBGQUPCGWM
Date   Source Headline
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20239:30 amRNSAdditional Listing
1st Feb 20239:15 amRNSAdditional Listing
31st Jan 20232:30 pmRNSDirector Declaration
31st Jan 202310:15 amRNSTotal Voting Rights
25th Jan 20239:15 amRNSAdditional Listing
17th Jan 20237:00 amRNSExperian Q3 FY23 trading update
13th Jan 20235:20 pmRNSFirst interim dividend
9th Jan 20237:00 amRNSDirectorate Change
30th Dec 202210:15 amRNSTotal Voting Rights
16th Dec 202211:30 amRNSElections for first interim dividend
14th Dec 20229:15 amRNSAdditional Listing
7th Dec 20229:00 amRNSAdditional Listing
30th Nov 202211:59 amRNSTotal Voting Rights
16th Nov 20227:00 amRNSHalf-year Report
31st Oct 20229:30 amRNSTotal Voting Rights
14th Oct 20229:51 amRNSShare Repurchase Programme
6th Oct 20227:00 amRNSDirectorate Change
5th Oct 20229:10 amRNSAdditional Listing
30th Sep 202212:06 pmRNSTotal Voting Rights
28th Sep 20229:02 amRNSAdditional Listing
19th Sep 202210:00 amRNSBlock listing Interim Review
14th Sep 20229:30 amRNSAdditional Listing
7th Sep 20229:30 amRNSAdditional Listing
31st Aug 202210:07 amRNSTotal Voting Rights
31st Aug 20229:30 amRNSAdditional Listing
17th Aug 20229:30 amRNSAdditional Listing
10th Aug 20229:15 amRNSAdditional Listing
29th Jul 20229:57 amRNSTotal Voting Rights
28th Jul 20229:25 amRNSDirector/PDMR Shareholding
21st Jul 202211:15 amRNSResult of AGM
21st Jul 202210:30 amRNSDirector Declaration
20th Jul 20229:30 amRNSAdditional Listing
14th Jul 20227:00 amRNSTrading update, first quarter
1st Jul 20225:42 pmRNSSecond Interim Dividend
30th Jun 20225:50 pmRNSTransaction in Own Shares
30th Jun 20224:00 pmRNSDirector/PDMR Shareholding
30th Jun 202210:54 amRNSTotal Voting Rights
29th Jun 20225:12 pmRNSTransaction in Own Shares
28th Jun 20225:28 pmRNSTransaction in Own Shares
27th Jun 20225:14 pmRNSTransaction in Own Shares
27th Jun 20222:15 pmRNSHolding(s) in Company
24th Jun 20225:41 pmRNSTransaction in Own Shares
24th Jun 202210:51 amRNSDirector/PDMR Shareholding
23rd Jun 20225:19 pmRNSTransaction in Own Shares
22nd Jun 20225:50 pmRNSTransaction in Own Shares
20th Jun 20225:26 pmRNSTransaction in Own Shares
17th Jun 20225:10 pmRNSTransaction in Own Shares
16th Jun 20225:33 pmRNSTransaction in Own Shares
15th Jun 20226:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.